McKesson plans $575M takeover of Oncology Therapeutics
McKesson Corp. has unveiled plans to acquire fellow drug distributor Oncology Therapeutics Network in a $575 million deal that would further expand McKesson's presence in the cancer drug market. The acquisition comes after McKesson's $1.1 billion takeover of Per-Se Technologies earlier this year. Forbes/Associated Press (10/04)
